Asper Biotech Ltd.

Asper Biotech is a genetic testing company specialized in retinal disorders, reproductive medicine and oncology. Asper Ophthalmics testing portfolio includes a comprehensive panel of tests targeting hereditary eye disorders. Asper Oncogenetics and Asper Reprogenetics offer the tests aimed respectively to determine cancer predisposition and reproductive problems.

The company’s unique technology Arrayed Primer Extension allows simultaneous, cost effective detection of hundreds DNA alterations in many different genes. In addition to APEX we offer full range of technologies such as sequencing technology and next-generation-sequencing.

Asper Biotech’s laboratory is an authorized medical laboratory, CLIA (99D2046227), ISO 15189:2008, and ISO 9001:2008 certified. Asper Biotech is participating in the European Molecular Genetics Quality Network (EMQN) quality assessment schemes in order to obtain the external quality control for mutation scanning and improve our testing services.